About N-[3-(difluoromethyl)-1-[4-[[[3-fluoro-1-[1-(6-hydroxy-2-oxopiperidin-3-yl)-5-methoxy-3-methyl-2-oxobenzimidazol-4-yl]piperidin-4-yl]-methylamino]methyl]cyclohexyl]pyrazol-4-yl]pyrazolo[1,5-a]pyrimidine-3-carboxamide
N-[3-(difluoromethyl)-1-[4-[[[3-fluoro-1-[1-(6-hydroxy-2-oxopiperidin-3-yl)-5-methoxy-3-methyl-2-oxobenzimidazol-4-yl]piperidin-4-yl]-methylamino]methyl]cyclohexyl]pyrazol-4-yl]pyrazolo[1,5-a]pyrimidine-3-carboxamide (PubChem CID 170086682) has the molecular formula C38H46F3N11O5
and a molecular weight of 793.85 g/mol. Its IUPAC name is N-[3-(difluoromethyl)-1-[4-[[[3-fluoro-1-[1-(6-hydroxy-2-oxopiperidin-3-yl)-5-methoxy-3-methyl-2-oxobenzimidazol-4-yl]piperidin-4-yl]-methylamino]methyl]cyclohexyl]pyrazol-4-yl]pyrazolo[1,5-a]pyrimidine-3-carboxamide.
Analyze N-[3-(difluoromethyl)-1-[4-[[[3-fluoro-1-[1-(6-hydroxy-2-oxopiperidin-3-yl)-5-methoxy-3-methyl-2-oxobenzimidazol-4-yl]piperidin-4-yl]-methylamino]methyl]cyclohexyl]pyrazol-4-yl]pyrazolo[1,5-a]pyrimidine-3-carboxamide with MolForge
Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.
Launch Full Analysis
Frequently Asked Questions
What is the IUPAC name of N-[3-(difluoromethyl)-1-[4-[[[3-fluoro-1-[1-(6-hydroxy-2-oxopiperidin-3-yl)-5-methoxy-3-methyl-2-oxobenzimidazol-4-yl]piperidin-4-yl]-methylamino]methyl]cyclohexyl]pyrazol-4-yl]pyrazolo[1,5-a]pyrimidine-3-carboxamide?
The IUPAC name of N-[3-(difluoromethyl)-1-[4-[[[3-fluoro-1-[1-(6-hydroxy-2-oxopiperidin-3-yl)-5-methoxy-3-methyl-2-oxobenzimidazol-4-yl]piperidin-4-yl]-methylamino]methyl]cyclohexyl]pyrazol-4-yl]pyrazolo[1,5-a]pyrimidine-3-carboxamide (CID 170086682) is N-[3-(difluoromethyl)-1-[4-[[[3-fluoro-1-[1-(6-hydroxy-2-oxopiperidin-3-yl)-5-methoxy-3-methyl-2-oxobenzimidazol-4-yl]piperidin-4-yl]-methylamino]methyl]cyclohexyl]pyrazol-4-yl]pyrazolo[1,5-a]pyrimidine-3-carboxamide.
What is the SMILES notation for N-[3-(difluoromethyl)-1-[4-[[[3-fluoro-1-[1-(6-hydroxy-2-oxopiperidin-3-yl)-5-methoxy-3-methyl-2-oxobenzimidazol-4-yl]piperidin-4-yl]-methylamino]methyl]cyclohexyl]pyrazol-4-yl]pyrazolo[1,5-a]pyrimidine-3-carboxamide?
The canonical SMILES for N-[3-(difluoromethyl)-1-[4-[[[3-fluoro-1-[1-(6-hydroxy-2-oxopiperidin-3-yl)-5-methoxy-3-methyl-2-oxobenzimidazol-4-yl]piperidin-4-yl]-methylamino]methyl]cyclohexyl]pyrazol-4-yl]pyrazolo[1,5-a]pyrimidine-3-carboxamide is COc1ccc2c(c1N1CCC(N(C)CC3CCC(n4cc(NC(=O)c5cnn6cccnc56)c(C(F)F)n4)CC3)C(F)C1)n(C)c(=O)n2C1CCC(O)NC1=O.
What is the InChIKey of N-[3-(difluoromethyl)-1-[4-[[[3-fluoro-1-[1-(6-hydroxy-2-oxopiperidin-3-yl)-5-methoxy-3-methyl-2-oxobenzimidazol-4-yl]piperidin-4-yl]-methylamino]methyl]cyclohexyl]pyrazol-4-yl]pyrazolo[1,5-a]pyrimidine-3-carboxamide?
The InChIKey is JDVHTDGFTMSISY-UHFFFAOYSA-N. The full InChI is InChI=1S/C38H46F3N11O5/c1-47(18-21-5-7-22(8-6-21)51-20-25(31(46-51)34(40)41)44-36(54)23-17-43-50-15-4-14-42-35(23)50)26-13-16-49(19-24(26)39)33-29(57-3)11-9-27-32(33)48(2)38(56)52(27)28-10-12-30(53)45-37(28)55/h4,9,11,14-15,17,20-22,24,26,28,30,34,53H,5-8,10,12-13,16,18-19H2,1-3H3,(H,44,54)(H,45,55).
What are the key properties of N-[3-(difluoromethyl)-1-[4-[[[3-fluoro-1-[1-(6-hydroxy-2-oxopiperidin-3-yl)-5-methoxy-3-methyl-2-oxobenzimidazol-4-yl]piperidin-4-yl]-methylamino]methyl]cyclohexyl]pyrazol-4-yl]pyrazolo[1,5-a]pyrimidine-3-carboxamide?
N-[3-(difluoromethyl)-1-[4-[[[3-fluoro-1-[1-(6-hydroxy-2-oxopiperidin-3-yl)-5-methoxy-3-methyl-2-oxobenzimidazol-4-yl]piperidin-4-yl]-methylamino]methyl]cyclohexyl]pyrazol-4-yl]pyrazolo[1,5-a]pyrimidine-3-carboxamide has a molecular weight of 793.85 g/mol, XLogP of 3.83, 10 rotatable bonds, 3 hydrogen bond donors, and 14 hydrogen bond acceptors.
Where does this data come from?
All data for N-[3-(difluoromethyl)-1-[4-[[[3-fluoro-1-[1-(6-hydroxy-2-oxopiperidin-3-yl)-5-methoxy-3-methyl-2-oxobenzimidazol-4-yl]piperidin-4-yl]-methylamino]methyl]cyclohexyl]pyrazol-4-yl]pyrazolo[1,5-a]pyrimidine-3-carboxamide is sourced from PubChem (CID 170086682), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).